ACT Capital Management’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $64K | Hold |
15,000
| – | – | 0.09% | 53 |
|
|
2022
Q2 | $68K | Sell |
15,000
-10,000
| -40% | -$45.3K | 0.1% | 57 |
|
|
2022
Q1 | $140K | Hold |
25,000
| – | – | 0.15% | 61 |
|
|
2021
Q4 | $156K | Sell |
25,000
-57,500
| -70% | -$359K | 0.11% | 72 |
|
|
2021
Q3 | $815K | Hold |
82,500
| – | – | 0.42% | 42 |
|
|
2021
Q2 | $735K | Buy |
+82,500
| New | +$735K | 0.38% | 52 |
|